{"id":"NCT00153803","sponsor":"Dartmouth-Hitchcock Medical Center","briefTitle":"Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)","officialTitle":"A National Web-Based Randomized Phase III Study of Erlotinib or Placebo Following Concurrent Docetaxel, Carboplatin, and Thoracic Radiotherapy in Patients With Inoperable Stage III Non-Small Cell Lung Cancer (D0410).","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-05","primaryCompletion":"2014-04","completion":"2014-04","firstPosted":"2005-09-12","resultsPosted":"2019-09-06","lastUpdate":"2019-09-06"},"enrollment":245,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Carcinoma, Non-Small-Cell Lung","Non-small Cell Lung Cancer","NSCLC"],"interventions":[{"type":"DRUG","name":"Erlotinib (tarceva)","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"PLACEBO_COMPARATOR"}],"summary":"This is a national, randomized, web-based, double-blind study to determine whether erlotinib (Tarceva) compared to placebo improves progression-free survival (PFS) for patients with inoperable, stage III NSCLC following concurrent docetaxel, carboplatin and thoracic radiotherapy. We hypothesize that the introduction of this orally active, well-tolerated agent following concurrent chemoradiation and prior to the emergence of drug resistance will prolong the progression-free survival by 40% (10 months â†’ 14 months).","primaryOutcome":{"measure":"Progression Free Survival","timeFrame":"5 years","effectByArm":[{"arm":"Tarceva","deltaMin":7.4,"sd":null},{"arm":"Placebo","deltaMin":8.1,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.165"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":4},"locations":{"siteCount":65,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":36,"n":118},"commonTop":["Hemoglobin","Constitutional symptoms - Fever","Fracture","Pain - Chest/Thorax","Allergic reaction"]}}